Application 021814

Type
NDA
Sponsor
BOEHRINGER INGELHEIM

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001APTIVUSTIPRANAVIRCAPSULE;ORAL250MGYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021814-001APTIVUSTIPRANAVIR250MGCAPSULE / ORALRLD, RS2005-06-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-2284e616aacf4f…
2026-08-18 06:07:402026-07N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-222680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-225bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-2279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-221e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-228072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-225c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-225d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-224b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-2274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-2287673890dc5c…
2021-03-12 10:30 UTC2021-03N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-225aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-228869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-223f01610625f2…
2019-09-15 20:21 UTC2019-09N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22b00525d2431f…
2019-07-19 19:46 UTC2019-07N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-226a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-221c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-229b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-223f0d92c62455…
2023-05-13 08:27 UTC2023-05N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22053a50430f4f…
2023-01-26 05:58 UTC2023-01N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-223bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-223a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021814-001APTIVUS250MGCAPSULE / ORALRLD, RS2005-06-22f41ea6bd6efb…

Observed Orange Book patent history#

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2019-12-13 00:20 UTC2019-12N021814-0016231887*PED2019-01-27Pediatric extension74a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021814-00158521952019-06-22Drug substance74a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021814-00161470952019-10-29U-67074a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021814-0015852195*PED2019-12-22Pediatric extension74a2ff9319b5…
2019-12-13 00:20 UTC2019-12N021814-0016147095*PED2020-04-29Pediatric extension74a2ff9319b5…
2020-12-22 03:56 UTC2020-12N021814-0016147095*PED2020-04-29Pediatric extension8869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021814-0016147095*PED2020-04-29Pediatric extensionc0c555d07b60…
2019-12-14 00:12 UTC2019-12N021814-0016231887*PED2019-01-27Pediatric extension3f01610625f2…
2019-12-14 00:12 UTC2019-12N021814-00158521952019-06-22Drug substance3f01610625f2…
2019-12-14 00:12 UTC2019-12N021814-00161470952019-10-29U-6703f01610625f2…
2019-12-14 00:12 UTC2019-12N021814-0015852195*PED2019-12-22Pediatric extension3f01610625f2…
2019-12-14 00:12 UTC2019-12N021814-0016147095*PED2020-04-29Pediatric extension3f01610625f2…
2019-09-15 20:21 UTC2019-09N021814-0016231887*PED2019-01-27Pediatric extensionb00525d2431f…
2019-09-15 20:21 UTC2019-09N021814-00158521952019-06-22Drug substanceb00525d2431f…
2019-09-15 20:21 UTC2019-09N021814-00161470952019-10-29U-670b00525d2431f…
2019-09-15 20:21 UTC2019-09N021814-0015852195*PED2019-12-22Pediatric extensionb00525d2431f…
2019-09-15 20:21 UTC2019-09N021814-0016147095*PED2020-04-29Pediatric extensionb00525d2431f…
2019-07-19 19:46 UTC2019-07N021814-0016231887*PED2019-01-27Pediatric extensionea99ee380514…
2019-07-19 19:46 UTC2019-07N021814-00158521952019-06-22Drug substanceea99ee380514…
2019-07-19 19:46 UTC2019-07N021814-00161470952019-10-29U-670ea99ee380514…
2019-07-19 19:46 UTC2019-07N021814-0015852195*PED2019-12-22Pediatric extensionea99ee380514…
2019-07-19 19:46 UTC2019-07N021814-0016147095*PED2020-04-29Pediatric extensionea99ee380514…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 5 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0597-0003AptivustipranavirBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0003AptivustipranavirBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0003AptivustipranavirBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0003AptivustipranavirBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0003AptivustipranavirBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
78060SUPPL 2024-04-04
78057SUPPL 2024-04-03
63652SUPPL2020-06-22
63633SUPPL2020-06-19
54857SUPPL2018-07-06
54716SUPPL2018-06-28
45375SUPPL2016-09-23
45343SUPPL2016-09-20
37697SUPPL2015-04-07
6243SUPPL2015-04-01
37696SUPPL2014-04-08
28646SUPPL2014-04-08
28645SUPPL2012-02-27
37695SUPPL2012-02-22
6242SUPPL2011-04-07
16416SUPPL2011-04-06
6241SUPPL2010-09-07
16415SUPPL2010-08-16
24218SUPPL2010-05-12
21827SUPPL2010-05-12
37694SUPPL2010-05-07
28644SUPPL2010-05-03
37693SUPPL2009-06-24
6240SUPPL2009-06-24
37692SUPPL2008-06-26
28643SUPPL2008-06-26
28642SUPPL2007-10-10
16414SUPPL2007-10-10
6239SUPPL2007-05-29
28641SUPPL2006-08-18
28640SUPPL2006-08-18
37691SUPPL2006-08-14
16413SUPPL2006-08-14
21826ORIG2005-09-02
28639ORIG2005-06-24
37690ORIG2005-06-23
53417ORIG1900-01-01
53416ORIG1900-01-01
53415ORIG1900-01-01